郑仲煊

创院院长
全球前2%顶尖科学家、加拿大健康科学院院士(CAHS)、香港中文大学荣誉教授、加拿大西安大略大学杰出荣誉教授、加拿大多伦多大学客席教授、加拿大医师领袖协会/医学学会印证高管医师 (CCPE)、加拿大皇家内外科医师学院院士 (RCPC)、英国皇家医学会会士 (RSM)、德国麻醉重症医学学会荣誉会士 (DGAI)、香港麻醉医师学院荣誉院士 (HKCA)

校长讲座教授, 教授

教育背景

医学博士(多伦多大学)

研究领域
循证临床决策、卫生技术评估、卫生政策、围手术期外科手术、麻醉护理、心脏外科、重症监护医学、人工智能医学教育与课程改革
电子邮件
davycheng@cuhk.edu.cn
个人简介

郑仲煊教授于2021年7月1日正式就任香港中文大学(深圳)医学院创院院长兼校长讲座教授。1977年,他毕业于加拿大渥太华大学,获生物化学学士学位;1979年毕业于加拿大西安大略大学,获生物化学硕士学位;1983年毕业于加拿大多伦多大学,获医学博士学位。1987年,他成为加拿大皇家内外科医师学院院士(RCPC);2007年,成为首位当选加拿大健康科学院院士(CAHS)的麻醉医师;2013年,当选英国皇家医学会会士(RSM)。2013年,郑教授被加拿大医学协会(CMA)和加拿大执业行政领导医师协会(CSPE)认定为加拿大医师领袖协会/医学学会印证高管医师(CCPE),并于2014年荣获加拿大执业医师协会杰出医学领袖奖。2014年,郑教授成为德国麻醉重症医学学会荣誉会士(DGAI);2022年成为香港麻醉科医学院荣誉院士 (HKCA)。

郑仲煊教授是心脏外科、麻醉和围手术期循证医学研究方面的世界权威。自2022年起,他两度入选了全球前2%顶尖科学家榜单,并荣登”终身科学影响力排行榜”(career-long impact)和“年度科学影响力排行榜”(2021 single-year impact)。他在快速心脏麻醉和康复方面的开创性工作已成为世界标准。目前,他的科研工作已获得超过1619万加元科研经费资助,发表SCI论文190多篇,参编论著60余本(被引数24081,H-index为68,I10-index 为148)。郑教授具有丰富的国际化专业经验,服务于众多国际专业委员会、组织和期刊。曾担任麻醉学(CJA)、心胸血管麻醉(JCTVA)和心脏外科(INNOVATIONS)等杂志编委。曾担任WHO认证的全球围手术期手术与麻醉护理联合中心的联合创始人与医学主任、加拿大大学麻醉协会(ACUDA)主席、国际麻醉研究学会(IARS)理事会主席与加拿大心脏麻醉医师协会(ACA)主席、国际微创心脏外科学会(ISMICS)、欧洲心胸协会(EACTS)以及世界卫生组织(WHO)实践准则制定指导委员会和专家小组的联合主席;曾受邀担任180多所大学、心脏中心、国内及国际会议的客座教授、特聘讲师和特邀嘉宾。

学术著作

被引数24109,H-index为68,i10-index 为148

World’s Top 2% Scientists List (2022, 2023).

1978年至今共发表SCI论文180多篇,参编论著60余本

部分学术著作:

  1. Benítez TM, Xu Y, Boudreau JD, Kow AWC, Bello F, Van Phuoc L, Wang X, Sun X, Leung GK, Lan Y, Wang Y, Cheng D*, Tham YC, Wong TY, Chung KC. Harnessing the potential of large language models in medical education: promise and pitfalls. J Am Med Inform Assoc. 2024 Feb 16;31(3):776-783. doi: 10.1093/jamia/ocad252.
  2. Conen D, Ke Wang M, Popova E, et al. Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): an international randomised trial. Lancet. 2023 Nov 4;402(10413):1627-1635. doi: 10.1016/S0140-6736(23)01689-6. Data and Safety Monitoring Committee
  3. Conen D, Popova E, Wang MK, et al. Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial. Am Heart J. 2023 May; 259:87-96. doi: 10.1016/j.ahj.2023.01.018. Data and Safety Monitoring Committee
  4. Le B, Flier S, Madill J, Joyes C, Dawson E, Wellington C, Adekunte S, Cheng D*, John-Baptiste A. Malnutrition risk, outcomes, and costs among older adults undergoing elective surgical procedures: A retrospective cohort study. Nutr Clin Pract. 2023 Aug 20. doi: 10.1002/ncp.11043.
  5. Li Z, Wijeysundera HC, Bagur R, Cheng D*, Martin J, Kiaii B, Qiu F, Fang J, John-Baptiste A. Performance of administrative database frailty instruments in predicting clinical outcomes and cost for patients undergoing transcatheter aortic valve implantation: a historical cohort study. Can J Anaesth. 2023 Jan; 70(1):116-129. English. doi: 10.1007/s12630-022-02354-6.
  6. Chan EYS, Cheng D*, Martin J. Magnitude of COVID-19 deaths relative to other leading causes of death: a global analysis. BMJ Open. 2022 Nov 25;12(11): e049689. doi: 10.1136/bmjopen-2021-049689.
  7. COVIDSurg Collaborative; GlobalSurg Collaborative. SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. Anaesthesia. 2022 Jan;77(1):28-39. doi: 10.1111/anae.15563. 
  8. Cheng DCH*, Martin J, David T, Editors (textbook). Evidence-based Practice in Perioperative Cardiac Anesthesia and Surgery. https://link.springer.com/book/10.1007%   2F978-3-030-47887-2; Springer Nature Switzerland AG 2021.
  9. COVIDSurg Collaborative; GlobalSurg Collaborative. Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study. Anaesthesia. 2021 Nov;76(11):1454-1464. doi: 10.1111/anae.15560.
  10. COVIDSurg Collaborative. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. Lancet Oncol. 2021 Nov;22(11):1507-1517. doi: 10.1016/S1470-2045(21)00493-9.
  11. COVIDSurg Collaborative, GlobalSurg Collaborative. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study. Br J Surg. 2021 Sep 27;108(9):1056-1063. doi: 10.1093/bjs/znab101.
  12.         Louise Hitchman, Matthew Machin, COVIDSurg Collaborative and Vascular and Endovascular Research Network. Impact of COVID-19 on vascular patients worldwide: analysis of the COVIDSurg data. J Cardiovasc Surg (Torino) 2021 Dec;62(6):558-570. doi: 10.23736/S0021-9509.21.12024-5.
  13. COVIDSurg Collaborative. Global wealth disparities drive adherence to COVID-safe pathways in head and neck cancer surgery. BJS Open. 2021 Nov 9;5(6): zrab112. doi: 10.1093/bjsopen/zrab112.
  14.  COVIDSurg Collaborative. Outcomes after perioperative SARS-CoV-2 infection in patients with proximal femoral fractures: an international cohort study. BMJ Open. 2021 Nov 30;11(11):e050830. doi: 10.1136/bmjopen-2021-050830.
  15.  Chan EYS, Cheng D*, Martin J. Impact of COVID-19 on excess mortality, life expectancy, and years of life lost in the United States. PLoS One. 2021 Sep 1;16(9): e0256835. doi: 10.1371/journal.pone.0256835.
  16.  Richard Shaw and COVIDSurg Collaborative. UK Head and neck cancer surgical capacity during the second wave of the COVID—19 pandemic: Have we learned the lessons? COVIDSurg collaborative. Clin Otolaryngol. 2021 Jul; 46(4): 729–735. doi: 10.1111/coa.13749
  17. The Cardiothoracic Interdisciplinary Research Network and COVIDSurg Collaborative. Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study. J Thorac Cardiovasc Surg. 2021 Apr 3. doi: 10.1016/j.jtcvs.2021.03.091.
  18.  COVIDSurg Collaborative and GlobalSurg Collaborative. Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. Anaesthesia. 2021;76(6):748-758. doi: 10.1111/anae.15458.
  19.  Li Z, Dawson E, Moodie J, Martin J, Bagur R, Cheng D*, Kiaii B, Hashi A, Bi R, Yeschin M, John-Baptiste A. Measurement and prognosis of frail patients undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis. BMJ Open. 2021 Mar 4;11(3): e040459. doi: 10.1136/bmjopen-2020-040459.
  20.  Yanagawa B, Ribeiro R, Lee J, Mazer CD, Cheng D*, Martin J, Verma S, Friedrich JO; Canadian Cardiovascular Surgery Meta-Analysis Working Group. Platelet Transfusion in Cardiac Surgery: A Systematic Review and Meta-Analysis. Ann Thorac Surg. 2021 Feb;111(2):607-614. doi: 10.1016/j.athoracsur.2020.04.139.
  21.  Li Z, Dawson E, Moodie J, Martin J, Bagur R, Cheng D*, Kiaii B, John-Baptiste A. Frailty in patients undergoing transcatheter aortic valve implantation: a protocol for a systematic review. BMJ Open. 2019 Feb 19;9(2): e024163. doi: 10.1136/bmjopen-2018-024163
  22.  Hong M, Jones PM, Martin J, Kiaii B, Arellano R, Cheng D*, John-Baptiste AA. Clinical impact of disinvestment in hydroxyethyl starch for patients undergoing coronary artery bypass surgery: a retrospective observational study. Can J Anaesth. 2019 Jan;66(1):25-35. PMID: 30411246
  23.  Wang L, Shen JT, Ge L, Arango MF, Tang X, Moodie J, McConnell B, Cheng D*, Martin J. Dexmedetomidine for craniotomy under general anesthesia: A systematic review and meta-analysis of randomized clinical trials. J Clin Anesth. 2019 May; 54:114-125. doi: 10.1016/j.jclinane.2018.11.001. Epub 2018 Nov 13.
  24.  Li JY, Gong J, Zhu F, Moodie J, Newitt A, Uruthiramoorthy L, Cheng D*, Martin J. Fibrinogen Concentrate in Cardiovascular Surgery: A Meta-analysis of Randomized Controlled Trials. Anesth Analg. 2018 Sep;127(3):612-621
  25.   Cheng D*, Barreiro G, Khan F, Mellin-Olsen J. Commentary on Burke TF et al. "Safety and Feasibility of a Ketamine Package to Support Emergency and Essential Surgery in Kenya when No Anesthetist is Available: An Analysis of 1216 Consecutive Operative Procedures". World J Surg. 2018 Sep;42(9):3042-3043.
  26.  Qureshi R, Sutton D, Cheng D*, Martin J. How fragile is the evidence base? A meta-epidemiologic study of the fragility index derived from 374 randomized trials. BMJ Evidence-Based Medicine 2018 Jun;23(Suppl 1): A20-A20.
  27.   Devereaux PJ, Duceppe E, Guyatt G, Tandon V, Rodseth R, Biccard BM, et al; MANAGE Investigators. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomized, placebo-controlled trial. Lancet. 2018 Jun 9;391(10137):2325-2334. DSMB
  28.   Chong M, Krishnan R, Cheng D*, Martin J. Should Transfusion Trigger Thresholds Differ for Critical Care versus Perioperative Patients? A Meta-Analysis of Randomized Trials. Critical Care Medicine, 2018 Feb; 46 (2): 252-263.